Innospec Statistics
Total Valuation
Innospec has a market cap or net worth of $2.73 billion. The enterprise value is $2.51 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 5, 2024, after market close.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | May 17, 2024 |
Share Statistics
Innospec has 24.94 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Shares Outstanding | 24.94M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 97.82% |
| Float | 24.65M |
Valuation Ratios
The trailing PE ratio is 18.16 and the forward PE ratio is 18.12. Innospec's PEG ratio is 2.42.
| PE Ratio | 18.16 |
| Forward PE | 18.12 |
| PS Ratio | 1.42 |
| Forward PS | 1.34 |
| PB Ratio | 2.27 |
| P/FCF Ratio | 16.41 |
| PEG Ratio | 2.42 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 10.70, with an EV/FCF ratio of 15.27.
| EV / Earnings | 16.81 |
| EV / Sales | 1.33 |
| EV / EBITDA | 10.70 |
| EV / EBIT | 12.98 |
| EV / FCF | 15.27 |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.63 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.29 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.06% and return on invested capital (ROIC) is 10.15%.
| Return on Equity (ROE) | 13.06% |
| Return on Assets (ROA) | 7.31% |
| Return on Capital (ROIC) | 10.15% |
| Revenue Per Employee | $789,167 |
| Profits Per Employee | $62,333 |
| Employee Count | 2,400 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 3.92 |
Taxes
In the past 12 months, Innospec has paid $42.20 million in taxes.
| Income Tax | 42.20M |
| Effective Tax Rate | 22.00% |
Stock Price Statistics
The stock price has increased by +8.79% in the last 52 weeks. The beta is 1.07, so Innospec's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +8.79% |
| 50-Day Moving Average | 111.15 |
| 200-Day Moving Average | 119.97 |
| Relative Strength Index (RSI) | 44.12 |
| Average Volume (20 Days) | 70,985 |
Short Selling Information
The latest short interest is 258,086, so 1.03% of the outstanding shares have been sold short.
| Short Interest | 258,086 |
| Short Previous Month | 250,363 |
| Short % of Shares Out | 1.03% |
| Short % of Float | 1.05% |
| Short Ratio (days to cover) | 2.56 |
Income Statement
In the last 12 months, Innospec had revenue of $1.89 billion and earned $149.60 million in profits. Earnings per share was $5.97.
| Revenue | 1.89B |
| Gross Profit | 580.50M |
| Operating Income | 193.70M |
| Pretax Income | 191.80M |
| Net Income | 149.60M |
| EBITDA | 234.90M |
| EBIT | 193.70M |
| Earnings Per Share (EPS) | $5.97 |
Full Income StatementBalance Sheet
The company has $240.20 million in cash and $48.10 million in debt, giving a net cash position of $192.10 million or $7.70 per share.
| Cash & Cash Equivalents | 240.20M |
| Total Debt | 48.10M |
| Net Cash | 192.10M |
| Net Cash Per Share | $7.70 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 47.82 |
| Working Capital | 544.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $215.80 million and capital expenditures -$51.10 million, giving a free cash flow of $164.70 million.
| Operating Cash Flow | 215.80M |
| Capital Expenditures | -51.10M |
| Free Cash Flow | 164.70M |
| FCF Per Share | $6.60 |
Full Cash Flow StatementMargins
Gross margin is 30.65%, with operating and profit margins of 10.23% and 7.90%.
| Gross Margin | 30.65% |
| Operating Margin | 10.23% |
| Pretax Margin | 10.13% |
| Profit Margin | 7.90% |
| EBITDA Margin | 12.40% |
| EBIT Margin | 10.23% |
| FCF Margin | 7.84% |